Blue Owl Capital Holdings LP Pyxis Oncology, Inc. Transaction History
Blue Owl Capital Holdings LP
- $303 Million
- Q3 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 1,126,025 shares of PYXS stock, worth $4.82 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
1,126,025
Previous 1,046,025
7.65%
Holding current value
$4.82 Million
Previous $3.46 Million
19.35%
% of portfolio
1.36%
Previous 1.44%
Shares
2 transactions
Others Institutions Holding PYXS
# of Institutions
100Shares Held
28.1MCall Options Held
539KPut Options Held
54.1K-
Deep Track Capital, LP Greenwich, CT4.18MShares$17.9 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.63MShares$15.5 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$10.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.91MShares$8.16 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $150M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...